Digestive Diseases and Sciences

, Volume 51, Issue 2, pp 365–369 | Cite as

Risk Factors for the Transmission of Hepatitis C Virus Infection in the Turkish Population

  • Çetin Karaca
  • Yilmaz Çakaloğlu
  • Kadir Demir
  • Sadakat Özdil
  • Sabahattin Kaymakoğlu
  • Selim Badur
  • Atilla Ökten
Liver

Abstract

The risk factors for the transmission of hepatitis C virus (HCV) infection varies substantially between countries and geographic regions. The aim of this investigation was to determine the risk factors which may be involved in the transmission of HCV infection in the Turkish population. This study included patients who were admitted to the Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, between 1996 and 2002 and found to be anti-HCV positive during hospitalization or during follow-up as outpatients. All patients were asked about risk factors for HCV transmission including transfusion, history of operation, hospitalization, hemodialysis, intravenous drug use, suspected sexual contact, tattooing, acupuncture, dental procedures, manicure and pedicure, blood brotherhood rituals, perinatal risk factors, common circumcision rituals, and history of abortion. In our study, total of 320 patients with anti-HCV seropositivity were involved. The numbers and percentages of male and female patients were 139 (43.4%) and 181 (56.6%), respectively. The mean age of the patients was 49.7± 12.4 years (range: 18–73 years). HCV-RNA was found to be positive in 297 (92.8%) patients. The most common risk factor was a history of surgery (305; 98%), and the second most common was blood transfusion (123; 39.7%). The numbers and percentages of patients for the other risk factors were as follows: dental procedure, 86 (27.5%); abortion, 66 (21.2%); long-term hospitalization, 37 (11.6%); hemodialysis, 31 (10%); history of jaundice, 15 (4.6%); history of intravenous drug abuse, 10 (3.1%); history of suspected sexual contact, 5 (1.5%); history of manicure and pedicure, 4 (1.2%); history of occupational transmission, 3 (0.9%); history of tattooing, 2 (0.6%); history of acupuncture, 2 (0.6%); circumcision in a common circumcision ritual, 1 (0.3%); and percutaneous needle puncture, 1 (0.3%). None of the patients had a history of blood brotherhood ritual or perinatal transmission. Only one risk factor was detected in 73 (22.8%) patients, two risk factors were detected in 122 (38.2%) patients, three risk factors were detected in 78 (24.5%) patients, and four risk factors were detected in 39 (12.2%) patients, however, in 8 (1.6%) patients no risk factors could be found. In Turkey, the most common risk factor for the transmission of HCV infection is surgery, which can be preventable.

Key Words

hepatitis C virus infection risk factor transmission 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Branch AD, Seeff LB: Foreword. Hepatitis C: State of the art at the millenium. Semin Liver Dis 20:iii, 2000Google Scholar
  2. 2.
    Mistik R, Balik I: Türkiye'de viral hepatitlerin epidemiyolojik analizi. In. Viral hepatit 2001. Vol 1. Bolum. Viral Hepatitle Savasim Dernegi. K. Kiliçturgay (ed). Istanbul, Nobel Tip Kitabevi, 2001, pp 9–55Google Scholar
  3. 3.
    Alter MJ, Gerety RJ, Smallwood L, Sampliner RE, Tabor E, Deinhardt F, Frosner G, Matanoski GM: Sporadic non-A, non-B hepatitis; frequency and epidemiology in the urban United States population. J Infect Dis 145:886–893, 1982PubMedGoogle Scholar
  4. 4.
    Okten A, Acar A, Cakaloglu Y, Boztas G; Kaymakoglu S, Yalcin S: Karaciger sirozunun etiyolojisi (1052 vaka analizi). T Kl Gastroenterohepatol 6:45–48, 1995Google Scholar
  5. 5.
    Cakaloglu Y, Okten A, Kaymakoglu S, Badur S, Yalcin S: Prevalence of antibody to hepatitis C virus in hepatitis B related and chronic alcholic liver disease and in blood donors in Türkiye. Turk J Med Biol Res 3:53–57, 1992Google Scholar
  6. 6.
    Thomas LD: Hepatitis C. Epidemiologic Quandaries. Clin Liver Dis 5:955–968, 2001Google Scholar
  7. 7.
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–443, 1981PubMedGoogle Scholar
  8. 8.
    Barut G, Hatemi I, Mert A, Kansak N, Senturk H: Toplumumuzda Anti-HCV pozitifligi. IV. Ulusal Hepatoloji Kongresi. Istanbul, Kongre Kitapçigi, 2001, p 118Google Scholar
  9. 9.
    Power JP, Lawer E, Davidson F, Yap PL, Kenny-Walsh E, Whelton MJ, Walsh TJ: Hepatitis C viremia in recipients of Irish intravenous anti-D immunoglobulin. Lancet 344:1165–1167, 1994CrossRefGoogle Scholar
  10. 10.
    Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion associated hepatitis C. N Engl J Med 332:1463–1466, 1995CrossRefPubMedGoogle Scholar
  11. 11.
    DiBisceglie AM, Goodman DZ, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ: Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 6:969–974, 1991Google Scholar
  12. 12.
    Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, Realdi G: Long-term follow-up of non-A, non-B (type C) posttransfusion hepatitis. J Hepatol 16:273–281, 1992CrossRefPubMedGoogle Scholar
  13. 13.
    Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671–675, 1990PubMedGoogle Scholar
  14. 14.
    Alter MJ, Margolis HS, Krawczyniski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE: The natural history of community-acquired hepatitis C in United States. N Engl J Med 327:1899–1905, 1992PubMedGoogle Scholar
  15. 15.
    Kelen GD, Green GB, Purcell RH, Chan DW, Qaqish BF, Sivertson KT, Quinn TC: Hepatitis B and hepatitis C in emergency department patients. N Engl J Med 326:1399–1404, 1992PubMedGoogle Scholar
  16. 16.
    Wasley A, Alter MJ: Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin Liver Dis 20:1–16, 2000CrossRefPubMedGoogle Scholar
  17. 17.
    Schvarcz R, Johansson B, Sönnerborg A: Nosocomial transmission of hepatitis C virus. Infection 25:74–77, 1997CrossRefPubMedGoogle Scholar
  18. 18.
    Allender T, Gruber A, Naghous M, Beyene A, Soderstrom T, Bjorkholm M, Grillner L, Persson M:. Frequent patient-to-patient transmission of hepatitis C virus in a heamotology ward. Lancet 345:603–605, 1995Google Scholar
  19. 19.
    Esteban JI, Gobez J, Martell M, Cabot B, Quer J, Camps J, Gonzalez A, Otero T, Moya A, Esteban R: Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 334:555–560, 1996CrossRefPubMedGoogle Scholar
  20. 20.
    Pereira BJ, Milford EL, Kirkman RL, Levey AS: Transmission of hepatitis C virus by organ transplantation. N Engl J Med 325:454–460, 1991PubMedGoogle Scholar
  21. 21.
    Chiaramonte M, Stroffolini T, Lorenzoni U, Minniti F, Conti S, Floreani A, Ntakirutimana E, Vian A, Ngatchu T, Naccarato R: Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol 24:129–134, 1996CrossRefPubMedGoogle Scholar
  22. 22.
    Bronowicki JP. Venard V, Botte C, Monhoven N, Gastin I, Chone L, Hudziak H, Rihn B, Delanoe C, LeFaou A, Bigard MA, Gaucher P: Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 337:7, 1997CrossRefGoogle Scholar
  23. 23.
    Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, Imai H, Nakano Y, Usuda S, Uemura K: Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterology 196:1596–1602, 1994Google Scholar
  24. 24.
    Yildirim B, Tabak F, Barut G, Mert A, Tahan V, Senturk H: HCV infeksiyonunda risk faktörleri. IV. Ulusal Hepatoloji Kongresi. Istanbul, Bildiri Kitapcigi, 2001, p 174Google Scholar
  25. 25.
    Bozkaya H: Hepatit C virus infeksiyonunun dogal seyri. In. C hepatiti tanive tedavisi. İstanbul, Ulusal Uzlaşma Toplantisi, 1999, pp 32–43Google Scholar
  26. 26.
    Edlin BR: Prevention and treatment of hepatitis C in injection drug users. Hepatology 36:210–219, 2002CrossRefGoogle Scholar
  27. 27.
    Cakaloglu Y: Hepatit C virus infeksiyonu epidemiyolojisi. Viral Hepatitis 29:551–556, 1994Google Scholar
  28. 28.
    Gorenek L, Ozguven V: HCV epidemiyolojisi. Gastroentero-Hepatoloji 12:124–128, 2001Google Scholar
  29. 29.
    Hoofnagle JH: Course and outcome of hepatitis C. Hepatology 36:21–29, 2002CrossRefGoogle Scholar
  30. 30.
    Abacioglu YH, Davidson F, Tuncer S, Yap PL, Ustacelebi S, Yulug N, Simmonds P: The distrubution of hepatitis C virus genotypes in Turkish patients. J Viral Hep 2:297–301, 1995Google Scholar
  31. 31.
    Arslan H, Tuncbilek S, Hizel N, Boyacioglu S: Hemodiyaliz ve hemodiyaliz dişihastalarda HCV genotipinin dagilimi. Viral Hepatit Der 2:127–130, 1999Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • Çetin Karaca
    • 1
    • 3
  • Yilmaz Çakaloğlu
    • 1
  • Kadir Demir
    • 1
  • Sadakat Özdil
    • 1
  • Sabahattin Kaymakoğlu
    • 1
  • Selim Badur
    • 2
  • Atilla Ökten
    • 1
  1. 1.Department of Gastroenterohepatology, İstanbul Medical Facultyİstanbul UniversityİstanbulTurkey
  2. 2.Departments of Microbiology and Immunology, İstanbul Medical Facultyİstanbul UniversityİstanbulTurkey
  3. 3.Şişli Etfal HastanesiŞişli/İstanbulTurkey

Personalised recommendations